Atlas Trials

A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout

Clinical trial NCT01736514 · COMPLETED

Trial details

NCT number
NCT01736514
Sponsor
Astellas Pharma Taiwan, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gout
Start date
2011-03-01
Primary completion
2012-02-01
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.